injection tirzepatide FDA Grants a New Indication for Obesity Management Tirzepatide

10.1016/j.prp.2017.12.009 17

Multi-indication label expansion: Semaglutide approved across obesity, cardiovascular risk reduction, MASH, and sleep apnea creates a total addressable patient population of approximately 640 million globally nearly four times the obesity-only base adding new prescriber populations including cardiologists, hepatologists, and sleep medicine specialists

Supports strength maintenance during caloric restriction

Response: We thank the commenters for raising this aspect of the measure

Alongside negative judgement of taking the drugs, there may be anxiety about supply and affordability, the spectre of weight regain and an altered relationship with food

Angiogenesis Mechanisms and Blood Vessel Modeling The pentadecapeptide component actively stimulates pathways responsible for angiogenesis, which scientists define as the formation of new blood vessels